Dingwei Ye
Impact in
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
- Renal cell carcinoma treatment
- Cancer Research top 2%
- MicroRNA in disease regulation
Papers in
-
- Prostate Cancer Treatment and Research 57
- Prostate Cancer Diagnosis and Treatment 35
- Renal cell carcinoma treatment 29
- Surgery 55
- Genital Health and Disease 25
- Bladder and Urothelial Cancer Treatments 22
- Co-authors
- Yao Zhu (97 shared papers)Bo Dai (50 shared papers)Guohai Shi (47 shared papers)Hai‐Liang Zhang (34 shared papers)Xu-Dong Yao (32 shared papers)Shi-Lin Zhang (32 shared papers)Bo Dai (27 shared papers)Yiping Zhu (29 shared papers)
- Journals
- Asian Journal of Andrology (19 papers)Oncotarget (10 papers)The Journal of Urology (9 papers)Journal of Cancer (9 papers)Frontiers in Oncology (8 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Dingwei Ye
194 papers receiving 5k citations
Peers
Comparison fields: 5 of 104
- Pulmonary and Respiratory Medicine 1.7k
- Cancer Research 669
- Oncology 661
- Geriatrics and Gerontology 74
- Surgery 854
Countries citing papers authored by Dingwei Ye
This map shows the geographic impact of Dingwei Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dingwei Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dingwei Ye more than expected).
Fields of papers citing papers by Dingwei Ye
This network shows the impact of papers produced by Dingwei Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dingwei Ye. The network helps show where Dingwei Ye may publish in the future.
Co-authors
The 25 scholars most cited alongside Dingwei Ye, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 199 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 502 | |
| 2 | 2015 | 208 | |
| 3 | 2019 | 157 | |
| 4 | 2012 | 155 | |
| 5 | 2018 | 131 | |
| 6 | 2010 | 130 | |
| 7 | 2020 | 120 | |
| 8 | 2019 | 115 | |
| 9 | 2019 | 111 | |
| 10 | 2018 | 87 | |
| 11 | 2010 | 85 | |
| 12 | 2012 | 70 | |
| 13 | 2013 | 64 | |
| 14 | 2015 | 63 | |
| 15 | 2017 | 62 | |
| 16 | 2012 | 57 | |
| 17 | 2012 | 54 | |
| 18 | CHEK2 mutation and risk of prostate cancer: a systematic review and meta-analysis. | 2015 | 53 |
| 19 | 2015 | 51 | |
| 20 | 2019 | 50 |
About Dingwei Ye
Dingwei Ye is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Genetics, Cancer Research and Oncology, having authored 199 papers that have together received 5.1k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (57 papers), Prostate Cancer Diagnosis and Treatment (35 papers), Renal cell carcinoma treatment (29 papers), Genital Health and Disease (25 papers), Bladder and Urothelial Cancer Treatments (22 papers), Genetic Associations and Epidemiology (16 papers), Cancer Immunotherapy and Biomarkers (8 papers) and BRCA gene mutations in cancer (8 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.7k citations), Cancer Research (669 citations), Oncology (661 citations), Geriatrics and Gerontology (74 citations) and Surgery (854 citations). Dingwei Ye has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Yao Zhu, Bo Dai, Guohai Shi, Hai‐Liang Zhang, Xu-Dong Yao, Shi-Lin Zhang, Bo Dai, Yiping Zhu, Guiming Zhang and Dalong Cao. Their work appears in journals such as Asian Journal of Andrology, Oncotarget, The Journal of Urology, Journal of Cancer and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.